Genetic Marker of Segregation: Sickle Cell Anemia, Thalassemia, and Racial Ideology in American Medical Writing 1920-1950
History and Philosophy of the Life Sciences 18 (3):305 - 320 (1996)
Abstract
This paper focuses on sickle cell anemia and thalassemia as case studies of genetic disease in America. Before the 1950s, these two diseases were perceived by many physicians as closely related (indeed, by some, as indistinguishable). Sickle cell anemia was defined by most American physicians as a Mendelian dominant disorder specific to African-Americans. As such, it could be 'spread' by any individual parent 'carrier' through reproduction. This view of the disease fed into (and was supported by) prevalent social concerns about miscegenation and, more generally, the dangers inherent in 'negro blood'. A particularly thorny problem for American physicians was how to explain cases of 'sickle cell anemia in white patients'. The paper examines how views about race, blood, and Mendelian genetics informed broader debates about the nature of hereditary disease and social relations in America from 1910 to 1950My notes
Similar books and articles
The use of race in medicine as a proxy for genetic differences.Michael Root - 2003 - Philosophy of Science 70 (5):1173-1183.
Sickle Cell Disease and the “Difficult Patient” Conundrum.Edward J. Bergman & Nicholas J. Diamond - 2013 - American Journal of Bioethics 13 (4):3 - 10.
Intractable Difficulties in Caring for People With Sickle Cell Disease.Helen Jane Crowther & Ian Kerridge - 2013 - American Journal of Bioethics 13 (4):22 - 24.
Not Your Typical Frequent Flyer: Overcoming Mythology in Caring for Sickle Cell Disease Patients.Dowin H. Boatright & Jean Abbott - 2013 - American Journal of Bioethics 13 (4):18 - 20.
The mystery of the mystery of common genetic diseases.Sean A. Valles - 2010 - Biology and Philosophy 25 (2):183-201.
Disrespectful Care in the Treatment of Sickle Cell Disease Requires More Than Ethics Consultation.Carlton Haywood - 2013 - American Journal of Bioethics 13 (4):12 - 14.
The “Difficult Patient” Conundrum in Sickle Cell Disease in Kenya: Complex Sociopolitical Problems Need Wide Multidimensional Solutions.Vicki Marsh, George Mocamah, Emmanuel Mabibo, Francis Kombe & Thomas N. Williams - 2013 - American Journal of Bioethics 13 (4):20 - 22.
Molecular Diseases and Diseased Molecules: Ontological and Epistemological Dimensions.Bruno J. Strasser & Bernardino Fantini - 1998 - History and Philosophy of the Life Sciences 20 (2):189 - 214.
Working up policy : the use of specific disease exemplars in formulating general principles governing childhood genetic testing. [REVIEW]Paula Boddington & Susan Hogben - 2006 - Health Care Analysis 14 (1):1-13.
Ethical issues related to computerised family medical histories in sickle cell disease: Inforare.S. Franrenet, N. Duchange, F. Galacteros, C. Quantin, O. Cohen, R. Nzouakou, S. Sudraud, C. Herve & G. Moutel - 2010 - Journal of Medical Ethics 36 (10):604-607.
Pain, Chronic Pain, and Sickle Cell Chronic Pain.Ron Amundson - 2013 - American Journal of Bioethics 13 (4):14 - 16.
Marketing in heterozygous advantage.Gregory Todd Jones & Reidar Hagtvedt - 2008 - Journal of Business Ethics 77 (1):85 - 97.
The Roles and Responsibilities of Physicians in Patients' Decisions about Unproven Stem Cell Therapies.Aaron D. Levine & Leslie E. Wolf - 2012 - Journal of Law, Medicine and Ethics 40 (1):122-134.
Analytics
Added to PP
2013-09-29
Downloads
39 (#300,974)
6 months
1 (#447,139)
2013-09-29
Downloads
39 (#300,974)
6 months
1 (#447,139)
Historical graph of downloads